These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 25725420)

  • 1. α-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease.
    Credle JJ; Forcelli PA; Delannoy M; Oaks AW; Permaul E; Berry DL; Duka V; Wills J; Sidhu A
    Neurobiol Dis; 2015 Apr; 76():112-125. PubMed ID: 25725420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease.
    Gorbatyuk MS; Shabashvili A; Chen W; Meyers C; Sullivan LF; Salganik M; Lin JH; Lewin AS; Muzyczka N; Gorbatyuk OS
    Mol Ther; 2012 Jul; 20(7):1327-37. PubMed ID: 22434142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the unfolded protein response in Parkinson's disease.
    Hoozemans JJ; van Haastert ES; Eikelenboom P; de Vos RA; Rozemuller JM; Scheper W
    Biochem Biophys Res Commun; 2007 Mar; 354(3):707-11. PubMed ID: 17254549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease.
    Bellucci A; Navarria L; Zaltieri M; Falarti E; Bodei S; Sigala S; Battistin L; Spillantini M; Missale C; Spano P
    J Neurochem; 2011 Feb; 116(4):588-605. PubMed ID: 21166675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response.
    Lee K; Tirasophon W; Shen X; Michalak M; Prywes R; Okada T; Yoshida H; Mori K; Kaufman RJ
    Genes Dev; 2002 Feb; 16(4):452-66. PubMed ID: 11850408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro reconstitution of ER-stress induced ATF6 transport in COPII vesicles.
    Schindler AJ; Schekman R
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17775-80. PubMed ID: 19822759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress.
    Tay KH; Luan Q; Croft A; Jiang CC; Jin L; Zhang XD; Tseng HY
    Cell Signal; 2014 Feb; 26(2):287-94. PubMed ID: 24240056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD) are characterised by differential activation of ER stress pathways: focus on UPR target genes.
    Montibeller L; de Belleroche J
    Cell Stress Chaperones; 2018 Sep; 23(5):897-912. PubMed ID: 29725981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Excessive Oxidative Protein Folding Is Protective in MPP(+) Toxicity-Induced Parkinson's Disease Models.
    Lehtonen Š; Jaronen M; Vehviläinen P; Lakso M; Rudgalvyte M; Keksa-Goldsteine V; Wong G; Courtney MJ; Koistinaho J; Goldsteins G
    Antioxid Redox Signal; 2016 Sep; 25(8):485-97. PubMed ID: 27139804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATF6-Mediated Unfolded Protein Response Facilitates Adeno-associated Virus 2 (AAV2) Transduction by Releasing the Suppression of the AAV Receptor on Endoplasmic Reticulum Stress.
    Cui M; Zhao Q; Wang J; Si Y; Cheng S; Ding W
    J Virol; 2022 Feb; 96(3):e0110321. PubMed ID: 34851146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response.
    Li B; Gao B; Ye L; Han X; Wang W; Kong L; Fang X; Zeng Y; Zheng H; Li S; Wu Z; Ye L
    Virus Res; 2007 Mar; 124(1-2):44-9. PubMed ID: 17092596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway.
    Mercado G; Castillo V; Soto P; Sidhu A
    Brain Res; 2016 Oct; 1648(Pt B):626-632. PubMed ID: 27103567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the ATF6 branch of the unfolded protein response in neurons improves stroke outcome.
    Yu Z; Sheng H; Liu S; Zhao S; Glembotski CC; Warner DS; Paschen W; Yang W
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):1069-1079. PubMed ID: 27217380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enforced dimerization between XBP1s and ATF6f enhances the protective effects of the UPR in models of neurodegeneration.
    Vidal RL; Sepulveda D; Troncoso-Escudero P; Garcia-Huerta P; Gonzalez C; Plate L; Jerez C; Canovas J; Rivera CA; Castillo V; Cisternas M; Leal S; Martinez A; Grandjean J; Sonia D; Lashuel HA; Martin AJM; Latapiat V; Matus S; Sardi SP; Wiseman RL; Hetz C
    Mol Ther; 2021 May; 29(5):1862-1882. PubMed ID: 33545358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of endoplasmic reticulum stress in neurodegenerative disease.
    Xiang C; Wang Y; Zhang H; Han F
    Apoptosis; 2017 Jan; 22(1):1-26. PubMed ID: 27815720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of EDEM1 functions enhance ATF6 pro-survival signaling.
    Papaioannou A; Higa A; Jégou G; Jouan F; Pineau R; Saas L; Avril T; Pluquet O; Chevet E
    FEBS J; 2018 Nov; 285(22):4146-4164. PubMed ID: 30281916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ERcentric view of Parkinson's disease.
    Mercado G; Valdés P; Hetz C
    Trends Mol Med; 2013 Mar; 19(3):165-75. PubMed ID: 23352769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astaxanthin inhibits apoptosis in a cell model of tauopathy by attenuating endoplasmic reticulum stress and unfolded protein response.
    Shi H; Zhao Y
    Eur J Pharmacol; 2024 Nov; 983():176962. PubMed ID: 39214273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease.
    Wang HQ; Takahashi R
    Antioxid Redox Signal; 2007 May; 9(5):553-61. PubMed ID: 17465880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UPR transducer BBF2H7 allows export of type II collagen in a cargo- and developmental stage-specific manner.
    Ishikawa T; Toyama T; Nakamura Y; Tamada K; Shimizu H; Ninagawa S; Okada T; Kamei Y; Ishikawa-Fujiwara T; Todo T; Aoyama E; Takigawa M; Harada A; Mori K
    J Cell Biol; 2017 Jun; 216(6):1761-1774. PubMed ID: 28500182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.